Far From Checkmate: Gastrointestinal Neoplasia Risk in Patients With Pathogenic Variants in CHEK2

被引：1
|
作者：
Sommovilla, Joshua [1 ,2 ]
Burke, Carol [1 ,2 ,3 ]
Liska, David [1 ,3 ]
机构：
[1] Cleveland Clin, Digest Dis & Surg Inst, Dept Colorectal Surg, Cleveland, OH USA
[2] Cleveland Clin, Sanford R Weiss MD Ctr Hereditary Colorectal Neopl, Digest Dis Inst, Dept Colorectal Surg, Cleveland, OH USA
[3] Cleveland Clin, Digest Dis & Surg Inst, Dept Gastroenterol Hepatol & Nutr, Cleveland, OH USA
来源：
DISEASES OF THE COLON & RECTUM | 2024年 / 67卷 / 10期
关键词：
BREAST-CANCER; SUSCEPTIBILITY;
D O I：
10.1097/DCR.0000000000003449
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1225 / 1226
页数：2
相关论文
共 50 条
  • [41] Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer
    Reiner, Anne S.
    Robson, Mark E.
    Mellemkjaer, Lene
    Tischkowitz, Marc
    John, Esther M.
    Lynch, Charles F.
    Brooks, Jennifer D.
    Boice, John D.
    Knight, Julia A.
    Teraoka, Sharon N.
    Liang, Xiaolin
    Woods, Meghan
    Shen, Ronglai
    Shore, Roy E.
    Stram, Daniel O.
    Thomas, Duncan C.
    Malone, Kathleen E.
    Bernstein, Leslie
    Riaz, Nadeem
    Woodward, Wendy
    Powell, Simon
    Goldgar, David
    Concannon, Patrick
    Bernstein, Jonine L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (12): : 1275 - 1278
  • [42] Cyclin D1 and CHEK2 polymorphic variants as low risk susceptibility alleles in DTC patients
    Szymon Hryhorowicz
    Katarzyna Ziemnicka
    Marta Kaczmarek-Rys
    Justyna Hoppe-Golebiewska
    Andrzej Plawski
    Marzena Skrzypczak-Zielinska
    Monika Golab
    Malgorzata Szkudlarek
    Batlomiej Budny
    Marek Ruchala
    Ryszard Slomsk
    Hereditary Cancer in Clinical Practice, 13 (Suppl 1)
  • [43] Survival from breast cancer in patients with CHEK2 mutations
    T. Huzarski
    C. Cybulski
    D. Wokolorczyk
    A. Jakubowska
    T. Byrski
    J. Gronwald
    P. Domagała
    M. Szwiec
    D. Godlewski
    E. Kilar
    E. Marczyk
    M. Siołek
    R. Wiśniowski
    H. Janiszewska
    D. Surdyka
    R. Sibilski
    P. Sun
    J. Lubiński
    S. A. Narod
    Breast Cancer Research and Treatment, 2014, 144 : 397 - 403
  • [44] Survival from breast cancer in patients with CHEK2 mutations
    Huzarski, T.
    Cybulski, C.
    Wokolorczyk, D.
    Jakubowska, A.
    Byrski, T.
    Gronwald, J.
    Domagala, P.
    Szwiec, M.
    Godlewski, D.
    Kilar, E.
    Marczyk, E.
    Siolek, M.
    Wisniowski, R.
    Janiszewska, H.
    Surdyka, D.
    Sibilski, R.
    Sun, P.
    Lubinski, J.
    Narod, S. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 397 - 403
  • [45] CHEK2 I157T-Pluto Among Numerous Low-Risk Genetic Factors Requiring Discharge From a Range of Pathogenic Variants?
    Ivanov, Maxim
    Sharova, Margarita
    Olsen, Andrea
    Lebedeva, Alexandra
    Ignatova, Ekaterina
    Mouse, Gerald
    Mileyko, Vladislav
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : XXV - XXV
  • [46] Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system
    Delimitsou, Angeliki
    Fostira, Florentia
    Kalfakakou, Despoina
    Apostolou, Paraskevi
    Konstantopoulou, Irene
    Kroupis, Christos
    Papavassiliou, Athanasios G.
    Kleibl, Zdenek
    Stratikos, Efstratios
    Voutsinas, Gerassimos E.
    Yannoukakos, Drakoulis
    HUMAN MUTATION, 2019, 40 (05) : 631 - 648
  • [47] Frequency of CHEK2 variants in a Romanian cohort of non-BRCA cancer patients
    Truica, Radu Alexandru
    Caragea, Andreea Mirela
    Filimon, Simona
    Cojocaru, Alexandra
    Popovici, Mirela
    Curici, Antoanela
    Bohiltea, Laurentiu
    Ursu, Radu-Ioan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 591 - 592
  • [48] Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma
    Havranek, Ondrej
    Kleiblova, Petra
    Hojny, Jan
    Lhota, Filip
    Soucek, Pavel
    Trneny, Marek
    Kleibl, Zdenek
    PLOS ONE, 2015, 10 (10):
  • [49] Comparing Cancer Risk Management between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants
    Garmendia, Diego
    Weidner, Anne
    Venton, Lindsay
    Pal, Tuya
    GENES, 2024, 15 (07)
  • [50] Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2
    Brzeskiewicz, Laura
    Roscow, Breanna
    Beeks, April
    Kunz, Barb
    Ratzel, Sarah
    Slavin, Thomas
    Cummings, Shelly
    Tedesco, Karen
    Reid, Robert
    GENETICS IN MEDICINE, 2022, 24 (03) : S34 - S34
12345